Literature DB >> 29970932

Use of Aborted Fetal Tissue in Vaccines and Medical Research Obscures the Value of All Human Life.

Kyle Christopher McKenna1.   

Abstract

This opinion addresses the licitness, quasi-benefits, and consequences of using aborted fetal tissue in vaccines and in medical research. The Catholic Church permits temporary use of vaccines generated using aborted fetal tissue to protect children from preventable diseases until alternative vaccines that do not use aborted fetal tissue are available. In medical research, cell lines that were generated from elective abortions should be avoided and alternative cell lines of licit origin utilized. The association between in utero Zika virus infections and microcephaly has increased the demand for fetal tissue to establish causality and to understand disease progression. These studies require extensive oversight as they could directly encourage elective abortions. The consequence of the use of fetal tissue from elective abortions is desensitization of beneficiaries to the original illicit act of abortion thereby obscuring the value of all human life and potentially leading to scandal. Summary: The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and in medical research. This opinion addresses the licitness, quasi-benefits, and consequences of using fetal tissue from elective abortions in vaccines and in medical research. All people of good conscience have the responsibility to voice opposition to the use of fetal tissue from elective abortions in order to promote development of alternatives, affirm the value of all human life and limit scandal.

Entities:  

Keywords:  abortion; ethics; fetal tissue; research; vaccine

Year:  2018        PMID: 29970932      PMCID: PMC6027112          DOI: 10.1177/0024363918761715

Source DB:  PubMed          Journal:  Linacre Q        ISSN: 0024-3639


  15 in total

1.  The ethics of HEK 293.

Authors:  Alvin Wong
Journal:  Natl Cathol Bioeth Q       Date:  2006

2.  Advantages of COS-1 monkey kidney epithelial cells as packaging host for small-volume production of high-quality recombinant lentiviruses.

Authors:  Shannon L Smith; Toshi Shioda
Journal:  J Virol Methods       Date:  2009-01-14       Impact factor: 2.014

Review 3.  Varicella vaccine effectiveness in the US vaccination program: a review.

Authors:  Jane F Seward; Mona Marin; Marietta Vázquez
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

4.  Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus.

Authors:  S A Plotkin; D Cornfeld; T H Ingalls
Journal:  Am J Dis Child       Date:  1965-10

5.  Zika Virus Associated with Microcephaly.

Authors:  Jernej Mlakar; Misa Korva; Nataša Tul; Mara Popović; Mateja Poljšak-Prijatelj; Jerica Mraz; Marko Kolenc; Katarina Resman Rus; Tina Vesnaver Vipotnik; Vesna Fabjan Vodušek; Alenka Vizjak; Jože Pižem; Miroslav Petrovec; Tatjana Avšič Županc
Journal:  N Engl J Med       Date:  2016-02-10       Impact factor: 91.245

6.  Elimination of rubella and congenital rubella syndrome--United States, 1969-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-25       Impact factor: 17.586

7.  Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Anthony E Fiore; Annemarie Wasley; Beth P Bell
Journal:  MMWR Recomm Rep       Date:  2006-05-19

Review 8.  Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.

Authors:  Varun K Phadke; Robert A Bednarczyk; Daniel A Salmon; Saad B Omer
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

9.  Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.

Authors:  Rita W Driggers; Cheng-Ying Ho; Essi M Korhonen; Suvi Kuivanen; Anne J Jääskeläinen; Teemu Smura; Avi Rosenberg; D Ashley Hill; Roberta L DeBiasi; Gilbert Vezina; Julia Timofeev; Fausto J Rodriguez; Lev Levanov; Jennifer Razak; Preetha Iyengar; Andrew Hennenfent; Richard Kennedy; Robert Lanciotti; Adre du Plessis; Olli Vapalahti
Journal:  N Engl J Med       Date:  2016-03-30       Impact factor: 91.245

Review 10.  Varicella vaccination in Europe - taking the practical approach.

Authors:  Paolo Bonanni; Judith Breuer; Anne Gershon; Michael Gershon; Waleria Hryniewicz; Vana Papaevangelou; Bernard Rentier; Hans Rümke; Catherine Sadzot-Delvaux; Jacques Senterre; Catherine Weil-Olivier; Peter Wutzler
Journal:  BMC Med       Date:  2009-05-28       Impact factor: 8.775

View more
  1 in total

1.  Religious Concerns About COVID-19 Vaccines: From Abortion to Religious Freedom.

Authors:  D Gareth Jones
Journal:  J Relig Health       Date:  2022-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.